Market›Health Care›Biotechnology›Biotechnology
IMMUCELL CORP

ICCC

$8.36Apr 26, 2021 – Apr 24, 2026
Health CareBiotechnology$66M
MVM
+$4.7M
TD Variance
0.327

Every news event mapped to its market reaction — 151 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-11-14-17.9%newsSeeking AlphaImmuCell signals operational excellence and targets $30M annual production capacity amid management transition
2025-11-14-17.9%earningsSeeking AlphaImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript
2025-04-08-17.1%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2022-11-21-12.5%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2022-01-05+11.3%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-12-02+10.9%legalSEC EDGARICCC 8-K: 1.01 and (SEC Filing)
2026-04-09+10.5%earningsSeeking AlphaImmuCell sees preliminary Q1 revenue of $10.4M
2026-04-09+10.5%newsCổng thông tin điện tử Tỉnh Sơn LaIs ImmuCell Corporation (ICCC) Stock undervalued by the market | Price at $7.26, Up 13.79% - Income Investing - Cổng thông tin điện tử Tỉnh Sơn La
2023-01-09+10.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-08-13-10.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-11-13-10.2%earningsSeeking AlphaImmuCell GAAP EPS of -$0.02, revenue of $5.50M
2025-11-13-10.2%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2022-08-11-9.8%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-02-25+9.6%earningsSeeking AlphaImmuCell GAAP EPS of $0.06, revenue of $7.75M
2025-02-25+9.6%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-05-14-9.1%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-08-15-8.8%newsSeeking AlphaImmuCell outlines cautious H2 outlook as capacity expansion supports First Defense suite
2025-08-15-8.8%earningsSeeking AlphaImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript
2025-04-07-8.5%legalSEC EDGARICCC 8-K: 1.01, 5.02 (SEC Filing)
2026-04-13+7.0%executiveGlobeNewswireImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
2026-04-13+7.0%newsStock TitanTwo animal health veterans join ImmuCell as board shrinks to 7 - Stock Titan
2026-04-13+7.0%newsStock TitanImmuCell (ICCC) adds industry veterans to a smaller, more independent board - Stock Titan
2022-10-05+6.9%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2026-04-23+6.5%newsStock TitanImmuCell (NASDAQ: ICCC) director lists 17,899 stock options - Stock Titan
2026-04-23+6.5%earningsCổng thông tin điện tử Tỉnh Sơn LaICCC ImmuCell Corporation shares gain nearly two percent following release of its Q4 2025 earnings report. - Retail Trader Ideas - Cổng thông tin điện tử Tỉnh Sơn La
2026-04-23+6.5%earningsCổng thông tin điện tử tỉnh Lào CaiICCC (ImmuCell Corporation) rises 1.78 percent after posting a 0.31 dollar per share loss for Q4 2025. - Cổng thông tin điện tử tỉnh Lào Cai
2026-04-23+6.5%newsStock TitanImmuCell (ICCC) director discloses 17,899 stock options grant details - Stock Titan
2025-02-26+6.4%earningsSeeking AlphaImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript
2025-12-26+6.4%newsMSNThe Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
2025-08-14-6.4%earningsSeeking AlphaImmuCell GAAP EPS of $0.06, revenue of $6.4M
2025-08-14-6.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-05-15+6.2%expansionSeeking AlphaImmuCell signals capacity expansion to $30M+ and launches new First Defense formats as backlog declines
2025-05-15+6.2%earningsSeeking AlphaImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript
2025-09-30+6.1%legalSEC EDGARICCC 8-K: 1.01, 5.02 (SEC Filing)
2026-02-09+6.0%legalSEC EDGARICCC 8-K: 5.02 and (SEC Filing)
2025-05-14+6.0%earningsSeeking AlphaImmuCell GAAP EPS of $0.16
2025-05-14+6.0%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-10-21+5.9%newsSeeking AlphaImmuCell Corporation: At A Major Inflection Point
2026-04-08+5.8%earningsMT NewswiresImmuCell Q1 Sales Jump; Shares Rise After Hours
2026-04-08+5.8%earningsGlobeNewswireImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
2026-04-08+5.8%newsSeeking AlphaStocks to watch after market on Wednesday: ICCC, COST, STZ
2026-04-08+5.8%earningsSeeking AlphaImmuCell Q1 sales jump 28.4% to $10.4M, led by Tri-Shield demand
2026-04-08+5.8%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2026-04-08+5.8%earningsStock TitanOne calf-health product drove ImmuCell's 28.4% Q1 sales jump - Stock Titan
2026-04-08+5.8%earningsStock TitanImmuCell (ICCC) Q1 2026 sales jump 28.4% on Tri-Shield strength - Stock Titan
2026-03-30-5.5%newsStock TitanImmuCell (NASDAQ: ICCC) boosts 2025 margins, shifts from Re‑Tain to core First Defense calf-health line - Stock Titan
2023-11-16-5.4%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2023-05-11-5.2%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2022-11-10-4.9%legalSEC EDGARICCC 8-K: 2.02, 4.02 (SEC Filing)
2022-08-17+4.9%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2021-08-24-4.9%legalSEC EDGARICCC 8-K: 7.01, 8.01 (SEC Filing)
2026-04-14+4.9%legalSEC EDGARICCC 8-K: 5.02, 8.01 (SEC Filing)
2026-04-14+4.9%newsStock TitanImmuCell (ICCC) director awarded 10,000 stock options at $5.49 strike - Stock Titan
2026-04-14+4.9%newsStock TitanImmuCell (ICCC) director awarded 10,000 options at $5.49 exercise price - Stock Titan
2026-04-14+4.9%newsStock TitanImmuCell (ICCC) VP Brockmann granted 5,000 incentive stock options - Stock Titan
2026-04-14+4.9%newsStock TitanImmuCell (ICCC) director receives grant of 10,000 stock options - Stock Titan
2026-04-14+4.9%newsStock TitanImmuCell (ICCC) director receives 10,000 non-qualified stock options at $5.49 - Stock Titan
2025-12-24+4.8%newsStock TitanHow a $900M calf-health market is reshaping this Maine animal company - Stock Titan
2022-04-11-4.7%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2021-08-12-4.6%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2023-02-21-4.6%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-01-10+4.5%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2023-07-21-4.4%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2024-10-08-4.3%earningsSeeking AlphaImmuCell announces preliminary results for Q3 2024
2024-10-08-4.3%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-11-14+4.2%earningsSeeking AlphaImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript
2026-03-05+4.0%earningsMobyImmuCell Corporation Q4 2025 Earnings Call Summary
2026-03-05+4.0%newsSeeking AlphaImmuCell outlines plan to boost First Defense capacity to 5–6M units while strengthening U.S. market share
2026-03-05+4.0%earningsSeeking AlphaImmuCell Corporation (ICCC) Q4 2025 Earnings Call Transcript
2024-01-08+4.0%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-08-14-3.9%earningsSeeking AlphaImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript
2026-01-07+3.8%newsStock TitanCattle firm ImmuCell shifts focus to calf product, previews 2025 sales - Stock Titan
2023-11-13-3.7%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2021-07-06+3.7%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2025-10-07+3.6%earningsSeeking AlphaImmuCell announces preliminary sales results for Q3
2025-10-07+3.6%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2026-04-16+3.5%earningsMarketBeatShort Interest in ImmuCell Corporation (NASDAQ:ICCC) Grows By 25.3% - MarketBeat
2026-04-16+3.5%newsStock Titan[Form 4] IMMUCELL CORP /DE/ Insider Trading Activity - Stock Titan
2026-04-16+3.5%newsStock TitanImmuCell (ICCC) grants director 11,933 stock options at $7.60 - Stock Titan
2026-04-16+3.5%newsStock TitanDirector Gloria Basse granted 11,933 ImmuCell (ICCC) stock options - Stock Titan
2026-04-16+3.5%newsStock TitanImmuCell (ICCC) director Paul Wainman receives 11,933 stock options at $7.60 - Stock Titan
2026-04-16+3.5%legalStock TitanICCC SEC Filings - Immucell 10-K, 10-Q, 8-K Forms - Stock Titan
2026-04-16+3.5%executiveMeykaICCC ImmuCell CEO Stock Option Filing April 16, 2026 - Meyka
2026-04-02+3.5%newsSeeking AlphaMaine governor backs millionaire tax as Senate primary tightens
2026-01-08+3.5%earningsSeeking AlphaImmuCell reports preliminary Q4 results
2026-01-08+3.5%legalSEC EDGARICCC 8-K: 2.02, 2.06, 8.01 (SEC Filing)
2024-07-09-3.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-03-06-3.4%legalSEC EDGARICCC 8-K: 1.01 and (SEC Filing)
2021-07-07+3.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-08-12-3.4%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2026-03-18+3.3%executiveGlobeNewswireImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
2026-03-18+3.3%legalSEC EDGARICCC 8-K: 5.02 and (SEC Filing)
2026-03-18+3.3%executiveStock TitanImmuCell (NASDAQ: ICCC) names Kathy Turner to Board as Rosgen retires - Stock Titan
2023-07-11+3.2%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-01-16+3.2%legalSEC EDGARICCC 8-K: 8.01 and (SEC Filing)
2026-04-22+3.0%analystZacksThe Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell
2025-09-29+3.0%executiveSeeking AlphaImmuCell appoints Olivier te Boekhorst as CEO
2026-04-21-2.8%newsZacksTop Stock Reports for Goldman Sachs, NextEra Energy & Shopify
2026-04-21-2.8%newsMeykaICCC ImmuCell Director Olivier Stock Option Filing April 2026 - Meyka
2026-03-07-2.7%earningsGuruFocus.comImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
2025-08-25+2.7%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2026-02-02-2.6%legalSEC EDGARICCC 8-K: 1.01, 5.02 (SEC Filing)
2023-02-28-2.6%legalSEC EDGARICCC 8-K: 5.02 (SEC Filing)
2025-07-09-2.5%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2026-03-06+2.5%newsZacksImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve
2026-03-06+2.5%earningsMarketBeatImmuCell Q4 Earnings Call Highlights
2022-05-12-2.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-11-04+2.3%executiveSeeking AlphammuCell appoints Olivier te Boekhorst as new CEO
2025-11-04+2.3%legalSEC EDGARICCC 8-K: 5.02 and (SEC Filing)
2026-04-03+2.2%newsCổng thông tin điện tử Tỉnh Sơn LaICCC Stock Analysis: ImmuCell Corporation animal health gains 1.42 pct at 6.44 - Cổng thông tin điện tử Tỉnh Sơn La
2025-06-25-2.1%executiveSeeking AlphaImmuCell initiates CEO succession search ahead of planned 2026 retirement
2025-06-25-2.1%legalSEC EDGARICCC 8-K: 8.01 and (SEC Filing)
2023-02-01-2.1%legalSEC EDGARICCC 8-K: 5.02 (SEC Filing)
2026-04-06+2.0%newsCổng thông tin điện tử Tỉnh Sơn LaCan ImmuCell Corporation (ICCC) Stock Double in 2026 | Price at $6.34, Down 1.55% - Sentiment Analysis - Cổng thông tin điện tử Tỉnh Sơn La
2022-02-11-2.0%legalSEC EDGARICCC 8-K: 1.01, 5.02 (SEC Filing)
2025-01-09+1.9%earningsSeeking AlphaImmuCell reports higher prelim Q4 sales
2022-07-07+1.9%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-12-09+1.9%legalSEC EDGARICCC 8-K: 1.01, 1.02, 5.02 (SEC Filing)
2021-11-15-1.7%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2022-02-22+1.7%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2023-06-21-1.6%legalSEC EDGARICCC 8-K: 5.02, 5.07 (SEC Filing)
2023-10-05+1.5%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-03-04+1.5%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2024-04-09-1.4%legalSEC EDGARICCC 8-K: 1.01 and (SEC Filing)
2024-04-09-1.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-06-14+1.3%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2021-10-06+1.3%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2022-07-28-1.0%legalSEC EDGARICCC 8-K: 8.01 and (SEC Filing)
2022-03-24+1.0%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2026-03-04-0.9%earningsSeeking AlphaImmuCell GAAP EPS of -$0.31, revenue of $7.62M
2026-03-04-0.9%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2026-03-04-0.9%newsStock TitanImmuCell (Nasdaq: ICCC) lifts 2025 EBITDA and narrows annual net loss - Stock Titan
2026-04-01+0.9%newsStock TitanIMMUCELL (ICCC) director Kathy V. Turner files initial insider Form 3 - Stock Titan
2024-11-13-0.8%earningsSeeking AlphaImmuCell GAAP EPS of -$0.09, revenue of $6.01M
2024-11-13-0.8%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2025-08-22+0.8%earningssimplywall.stImmuCell (NASDAQ:ICCC) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of - simplywall.st
2023-04-05-0.7%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-02-27+0.7%legalSEC EDGARICCC 8-K: 1.01, 2.03 (SEC Filing)
2024-02-27+0.7%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2026-01-09+0.7%earningsSeeking AlphaImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
2026-04-18+0.7%legalCổng thông tin điện tử tỉnh Lào CaiImmuCell Corporation (ICCC) Stock: Trend Direction (Climbs) 2026-04-18 - Sector Rotation - Cổng thông tin điện tử tỉnh Lào Cai
2026-04-18+0.7%newsXã Thanh HàImmuCell Corporation (ICCC) Stock: Trend Direction (Climbs) 2026-04-18 - Top Trending Breakouts - Xã Thanh Hà
2024-09-24+0.5%legalSEC EDGARICCC 8-K: 1.01, 2.03, 5.03 (SEC Filing)
2023-08-10-0.4%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2021-05-13+0.3%legalSEC EDGARICCC 8-K: 2.02 and (SEC Filing)
2024-06-06-0.3%legalSEC EDGARICCC 8-K: 8.01 and (SEC Filing)
2025-12-29+0.3%legalSEC EDGARICCC 8-K: 2.06, 8.01 (SEC Filing)
2026-03-24+0.2%newsStock TitanImmuCell (ICCC) director exercises 25,000 options and ends with 205,700 shares - Stock Titan
2025-10-20+0.1%newsSeeking AlphaImmuCell Corporation: At A Major Inflection Point (ICCC) - Seeking Alpha
2026-04-24—newsStock TitanImmuCell (NASDAQ: ICCC) outlines 2026 strategy, equity plan and pay - Stock Titan
2026-04-24—executiveMeykaICCC ImmuCell CEO Paul te Boekhorst Stock Option Filing April 2026 - Meyka
tickerdossier.comtickerdossier.substack.com